Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: A systematic review

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Cleynen, Isabelle ^a   Jüni, Peter ^b,c   Bekkering, Geertruida E ^a   Nüesch, Eveline ^b,c   Mendes, Camila T ^b   Schmied, Stefanie ^b   Wyder, Stefan ^b   Kellen, Eliane ^d   Villiger, Peter M ^b   Rutgeerts, Paul ^a   Vermeire, Séverine ^a   Lottaz, Daniel ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLAMINOACYL PEPTIDASE GENE; CHROMOSOME 16; CHROMOSOME 3; CROHN DISEASE; CYLINDROMATOSIS GENE; DISEASE ASSOCIATION; DYSTROGLYCAN GENE; EUROPE; GENE; GENE FUNCTION; GENE LOCATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC SELECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE STIMULATING PROTEIN GENE; MATRIX METALLOPROTEASE 2 GENE; MEMBRANE TYPE MATRIX PROTEASE 2 GENE; PEROXIMAL LON PEPTIDASE GENE; PROTEASE GENE; PROTEASE INHIBITOR GENE; REVIEW; SYSTEMATIC REVIEW; UBIQUITIN SPECIFIC PEPTIDASE 4 GENE; ULCERATIVE COLITIS; ENTERITIS; GENETIC PREDISPOSITION; GENETICS; PROTEIN DATABASE;

ACYLAMINOACYL PEPTIDASE; ACYLAMINOACYL-PEPTIDASE; CYLD PROTEIN, HUMAN; DYSTROGLYCAN; MACROPHAGE STIMULATING PROTEIN; ONCOPROTEIN; PEPTIDE HYDROLASE; PROTEINASE INHIBITOR; SCATTER FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE; USP4 PROTEIN, HUMAN;

DATABASES, PROTEIN; DYSTROGLYCANS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATORY BOWEL DISEASES; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 80052519447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024106     Document Type: Review

References (110)

1. Loftus EV Jr, Sandborn WJ, (2002) Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 31: 1-20.
2. Loftus EV Jr, (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. 126: 1504-1517.
3. Carter MJ, Lobo AJ, Travis SP, (2004) Guidelines for the management of inflammatory bowel disease in adults. Gut 53 (Suppl 5): V1-16.
4. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. 448: 427-434.
5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. 411: 599-603.
6. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. 411: 603-606.
7. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. 314: 1461-1463.
8. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. 39: 596-604.
9. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, et al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. 39: 830-832.
10. Rawlings ND, Morton FR, Barrett AJ, (2006) MEROPS: the peptidase database. Nucleic Acids Res 34: D270-272.
11. Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, et al. (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40: 710-712.
12. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, et al. (2008) Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 40: 1319-1323.
13. Franke A, Balschun T, Karlsen TH, Hedderich J, May S, et al. (2008) Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 40: 713-715.
14. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. 40: 955-962.
15. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. 447: 661-678.
16. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. 39: 207-211.
17. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. 3: e58.
18. Raelson JV, Little RD, Ruether A, Fournier H, Paquin B, et al. (2007) Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. 104: 14747-14752.
19. Franke A, Hampe J, Rosenstiel P, Becker C, Wagner F, et al. (2007) Systematic association mapping identifies NELL1 as a novel IBD disease gene. 2: e691.
20. Bottini N, Gloria-Bottini F, Amante A, Saccucci P, Bottini E, (2005) Genetic polymorphism and TH1/TH2 orientation. 138: 328-333.
21. Cuthbert AP, Fisher SA, Lewis CM, Mathew CG, Sanderson J, et al. (2004) Genetic association between EPHX1 and Crohn's disease: population stratification, genotyping error, or random chance? 53: 1386.
22. Elmgreen J, Sorensen H, Berkowicz A, (1984) Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease. 215: 375-378.
23. Haslam N, Standen GR, Probert CS, (2001) An investigation of the association of the prothrombin G20210A gene mutation and inflammatory bowel disease: Factor II and IBD. 7: 133-135.
24. Hume GE, Fowler EV, Lincoln D, Eri R, Templeton D, et al. (2006) Angiotensinogen and transforming growth factor beta1: novel genes in the pathogenesis of Crohn's disease. 43: e51.
25. Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Hommes DW, et al. (2007) Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. 13: 2960-2966.
26. Over-Hamzaoglu H, Abaci N, Ture F, Alkim C, Tezel A, et al. (2005) Prothrombotic gene mutations and Crohn's disease; is there any association? 52: 1467-1469.
27. Peters WH, van der Logt EM, Te Morsche RH, Roelofs HM, de Jong DJ, et al. (2005) No genetic association between EPHX1 and Crohn's disease. 54: 1659-1660.
28. Pender SL, Croucher PJ, Mascheretti S, Prothero JD, Fisher SA, et al. (2004) Transmission disequilibrium test of stromelysin-1 gene variation in relation to Crohn's disease. 41: e112.
29. Vecchi M, Sacchi E, Saibeni S, Meucci G, Tagliabue L, et al. (2000) Inflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosis. 45: 1465-1469.
30. Yilmaz S, Bayan K, Tuzun Y, Batun S, Altintas A, (2006) A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey. 22: 205-212.
31. Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, et al. (2007) Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients. 54: 1438-1442.
32. Akolkar PN, Gulwani-Akolkar B, Lin XY, Zhou Z, Daly M, et al. (2001) The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease. 96: 1127-1132.
33. Annese V, Latiano A, Bovio P, Forabosco P, Piepoli A, et al. (1999) Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study. 7: 567-573.
34. Annese V, Latiano A, Palmieri O, Li HH, Forabosco P, et al. (2003) w. 40: 837-841.
35. Brant SR, Fu Y, Fields CT, Baltazar R, Ravenhill G, et al. (1998) American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. 115: 1056-1061.
36. Cavanaugh JA, Callen DF, Wilson SR, Stanford PM, Sraml ME, et al. (1998) Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. 62: 291-298.
37. Cho JH, Fu Y, Kirschner BS, Hanauer SB, (1997) Confirmation of a susceptibility locus for Crohn's disease on chromosome 16. 3: 190.
38. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. 95: 7502-7507.
39. Curran ME, Lau KF, Hampe J, Schreiber S, Bridger S, et al. (1998) Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. 115: 1066-1071.
40. Dechairo B, Dimon C, van HD, Mackay I, Edwards M, et al. (2001) Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). 9: 627-633.
41. Duerr RH, Barmada MM, Zhang L, Davis S, Preston RA, et al. (1998) Linkage and association between inflammatory bowel disease and a locus on chromosome 12. 63: 95-100.
42. Duerr RH, Barmada MM, Zhang L, Achkar JP, Cho JH, et al. (2002) Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. 11: 2599-2606.
43. Farmer M, Hunt L, Eichenberger MR, Petras RE, Janosky JE, et al. (2001) Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease. 46: 632-636.
44. Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, et al. (1999) A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. 64: 808-816.
45. Hampe J, Lynch NJ, Daniels S, Bridger S, MacPherson AJ, et al. (2001) Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. 48: 191-197.
46. Hampe J, Frenzel H, Mirza MM, Croucher PJ, Cuthbert A, et al. (2002) Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. 99: 321-326.
47. Herbon N, Werner M, Braig C, Gohlke H, Dutsch G, et al. (2003) High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. 81: 510-518.
48. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Caillat-Zucman S, Beaugerie L, et al. (1994) Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn disease. GETAID 52: 207-213.
49. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, et al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. 379: 821-823.
50. Lesage S, Zouali H, Colombel JF, Belaiche J, Cezard JP, et al. (2000) Genetic analyses of chromosome 12 loci in Crohn's disease. 47: 787-791.
51. Low JH, Williams FA, Yang X, Cullen S, Colley J, et al. (2004) Inflammatory bowel disease is linked to 19p13 and associated with ICAM-1. 10: 173-181.
52. Mirza MM, Lee J, Teare D, Hugot JP, Laurent-Puig P, et al. (1998) Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. 35: 218-221.
53. Ohmen JD, Yang HY, Yamamoto KK, Zhao HY, Ma Y, et al. (1996) Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. 5: 1679-1683.
54. Paavola-Sakki P, Ollikainen V, Helio T, Halme L, Turunen U, et al. (2002) Genome-wide search in Finnish families with inflammatory bowel disease provides evidence for novel susceptibility loci. 11: 112-120.
55. Paavola P, Helio T, Kiuru M, Halme L, Turunen U, et al. (2001) Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. 9: 328-334.
56. Parkes M, Satsangi J, Lathrop GM, Bell JI, Jewell DP, (1996) Susceptibility loci in inflammatory bowel disease. 348: 1588.
57. Pierik M, Yang H, Barmada MM, Cavanaugh JA, Annese V, et al. (2005) The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. 11: 1-7.
58. Rioux JD, Daly MJ, Green T, Stone V, Lander ES, et al. (1998) Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. 115: 1062-1065.
59. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. 66: 1863-1870.
60. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. 29: 223-228.
61. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, et al. (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. 14: 199-202.
62. Tello-Ruiz MK, Curley C, DelMonte T, Giallourakis C, Kirby A, et al. (2006) Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. 14: 780-790.
63. Uthoff SM, Crawford NP, Eichenberger MR, Hamilton CJ, Petras RE, et al. (2002) Association of ulcerative colitis with the inflammatory bowel disease susceptibility locus IBD2 in non-Jewish Caucasians and evidence of genetic heterogeneity among racial and ethnic populations with Crohn disease. 113: 242-249.
64. Vermeire S, Peeters M, Vlietinck R, Parkes M, Satsangi J, et al. (2000) Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity. 6: 165-170.
65. Yang H, Ohmen JD, Ma Y, Bentley LG, Targan SR, et al. (1999) Additional evidence of linkage between Crohn's disease and a putative locus on chromosome 12. 1: 194-198.
66. Zouali H, Chamaillard M, Lesage S, Cezard JP, Colombel JF, et al. (2001) Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel disease. 9: 731-742.
67. Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, et al. (2004) A genome scan in 260 inflammatory bowel disease-affected relative pairs. 10: 15-22.
68. Duerr RH, Barmada MM, Zhang L, Pfutzer R, Weeks DE, (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. 66: 1857-1862.
69. Ma Y, Ohmen JD, Li Z, Bentley LG, McElree C, et al. (1999) A genome-wide search identifies potential new susceptibility loci for Crohn's disease. 5: 271-278.
70. van Heel DA, Dechairo BM, Dawson G, McGovern DP, Negoro K, et al. (2003) The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants. 12: 2569-2575.
71. Vermeire S, Rutgeerts P, Van SK, Joossens S, Claessens G, et al. (2004) Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. 53: 980-986.
72. Williams CN, Kocher K, Lander ES, Daly MJ, Rioux JD, (2002) Using a genome-wide scan and meta-analysis to identify a novel IBD locus and confirm previously identified IBD loci. 8: 375-381.
73. Almeida S, Maillard C, Itin P, Hohl D, Huber M, (2008) Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 128: 587-593.
74. Young AL, Kellermayer R, Szigeti R, Teszas A, Azmi S, et al. (2006) CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes. Clin Genet 70: 246-249.
75. Blake PW, Toro JR, (2009) Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum Mutat 30: 1025-1036.
76. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature genetics 42: 1118-1125.
77. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature genetics 43: 246-252.
78. Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, et al. (2005) Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med 2: e199.
79. Zhang J, Stirling B, Temmerman ST, Ma CA, Fuss IJ, et al. (2006) Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Invest 116: 3042-3049.
80. Nguyen KT, Pei D, (2005) Purification and characterization of enzymes involved in the degradation of chemotactic N-formyl peptides. Biochemistry 44: 8514-8522.
81. Feller M, Huwiler K, Stephan R, Altpeter E, Shang A, et al. (2007) Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis 7: 607-613.
82. Warth A, (2008) Is alpha-dystroglycan the missing link in the mechanism of enterocyte uptake and translocation of Mycobacterium avium paratuberculosis? Med Hypotheses 70: 369-374.
83. Paul S, (2008) Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 30: 1172-1184.
84. Goyette P, Lefebvre C, Ng A, Brant SR, Cho JH, et al. (2008) Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol 1: 131-138.
85. Van Limbergen J, Wilson DC, Satsangi J, (2009) The genetics of Crohn's disease. Annu Rev Genomics Hum Genet 10: 89-116.
86. Hedges LV, Olkin I, (1980) Vote-Counting Methods in Research Synthesis. Psychological Bulletin 88: 359-369.
87. Friedman L, (2001) Why vote-count reviews don't count. Biological psychiatry 49: 161-162.
88. Strober W, Kitani A, Fuss I, Asano N, Watanabe T, (2008) The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol 1 (Suppl 1): S5-9.
89. Van Limbergen J, Russell RK, Nimmo ER, Satsangi J, (2007) The genetics of inflammatory bowel disease. 102: 2820-2831.
90. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, et al. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. 13: 763-770.
91. Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA, et al. (2009) Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41: 1330-1334.
92. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, et al. (2009) Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41: 1335-1340.
93. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, et al. (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40: 1211-1215.
94. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, et al. (2009) Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 41: 216-220.
95. Marquez A, Cenit MC, Nunez C, Mendoza JL, Taxonera C, et al. (2009) Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun 10: 631-635.
96. Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, et al. (2008) Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12.2. Gastroenterology 135: 1207-1215.
97. Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, et al. (2010) Genetic analysis in a dutch study sample identifies more ulcerative colitis susceptibility Loci and shows their additive role in disease risk. Am J Gastroenterol 105: 395-402.
98. Banerjee S, Oneda B, Yap LM, Jewell DP, Matters GL, et al. (2009) MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal Immunol 2: 220-231.
99. Tomer G, Wetzler G, Keddache M, Denson LA, (2009) Polymorphisms in the IBD5 locus are associated with Crohn disease in pediatric Ashkenazi Jewish patients. J Pediatr Gastroenterol Nutr 48: 531-537.
100. Weersma RK, Stokkers PC, Cleynen I, Wolfkamp SC, Henckaerts L, et al. (2009) Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort. Am J Gastroenterol 104: 630-638.
101. Hubbard TJ, Aken BL, Ayling S, Ballester B, Beal K, et al. (2009) Ensembl 2009. Nucleic Acids Res 37: D690-697.
102. Sayers EW, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2009) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 37: D5-15.
103. Kingsmore SF, Lindquist IE, Mudge J, Gessler DD, Beavis WD, (2008) Genome-wide association studies: progress and potential for drug discovery and development. 7: 221-230.
104. Mathew CG, (2008) New links to the pathogenesis of Crohn disease provided by genome-wide association scans. 9: 9-14.
105. Noble C, Nimmo E, Gaya D, Russell RK, Satsangi J, (2006) Novel susceptibility genes in inflammatory bowel disease. 12: 1991-1999.
106. Ferguson LR, Philpott M, Dryland P, (2007) Nutrigenomics in the whole-genome scanning era: Crohn's disease as example. 64: 3105-3118.
107. Lander E, Kruglyak L, (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247.
108. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37: 120-132.
109. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851-861.
110. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431: 931-945.